Tumor Tissue
Tumor Tissue is an intervention with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening
Biobank for African American Prostate Cancer Research in Florida
Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
Identification of a MOLecuLar Signature in Locally Advanced Cervical Cancer Patients
Clinical Trials (7)
Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening
Biobank for African American Prostate Cancer Research in Florida
Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
Identification of a MOLecuLar Signature in Locally Advanced Cervical Cancer Patients
Genomic Profiling Assay in Phase I
MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer
All 7 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 7